CorMedin®

CorMedin®

Pimobendan Tablets for Dogs

Pimobendan is a benzimidazole-pyridazinone derivative, and is a non-sympathomimetic, non-glycoside inotropic substance with potent vasodilatative properties.

On this page
Technical Information

CorMedin is a pimobendan product available in 1.25 mg, 2.5 mg and 5 mg sizes. CorMedin can be used to treat canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and / or tricuspid regurgitation).

Learn More

Technical Information

Active Constituent(s)

Each tablet contains 1.25 mg, 2.5 mg or 5 mg pimobendan

Indications

CorMedin Tablets for Dogs are indicated for:

  • The treatment of canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and / or tricuspid regurgitation).
  • The treatment of preclinical DCM in large breeds. When used in cases of preclinical DCM in large breed dogs, pimobendan significantly prolonged the time to the onset of CHF or sudden death, and also resulted in prolongation of the time to death due to all causes.
  • Doberman Pinscher dogs with preclinical DCM treated with  pimobendan also demonstrated a significant reduction in Left Ventricular Internal Diameter in both systole and diastole (LVIDs/d) in response to therapy.

Dosage

Body-weight (kg) Pimobendan dosage 0.2 – 0.6 mg / kg daily divided into two treatments given
in the morning and in the evening
No. of tablets per administration
Morning Evening
1.25 mg 2.5 mg 5.0 mg 1.25 mg 2.5 mg 5.0 mg
5 – 10 1 1
>10 – 20 1 1
>20 – 40

(select either row)

2 2
1 1
>40 – 60 2 2
>60 – 80 3 3
>80 4 4

 

Product Codes

Size Code
CorMedin 1.25 mg x 84 Tabs 521105
CorMedin 2.5 mg x 84 Tabs 521110
CorMedin 5 mg x 84 Tabs 521115

Are you a veterinarian?

To view our range of veterinary products please confirm that you are a veterinarian and you will be redirected to our product list.